Robert a Bermel1, Salim E. Abboud1,
Blessy Mathew2, Ken E. Sakaie2, Stephen E. Jones2,
Michael D. Phillips2, Mark J. Lowe2
1Neurological Institute,
Transsynaptic degeneration may occur in response to demyelinating disease, and may represent a future therapeutic target for neuroprotection in MS. We use optic neuritis as a model system to identify transsynaptic changes in the visual pathways, using multimodal imaging.